Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome

NCT03162094 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndrome

Interventions

DRUG: AVX012 Ophthalmic Solution Low dose
DRUG: AVX012 Ophthalmic Solution High dose
DRUG: Placebo (vehicle)

Sponsor

Avizorex Pharma, S.L.